Search results
Open to inorganic opportunities in specialty drugs, says Sun Pharma
Business Standard India· 2 hours agoSun Pharma has net cash position of $2.4 bn at end of FY24; 6 new specialty products in R&D pipeline
Today’s Latest Business News, Finance and Share Market News at 10:00 am on 4 July 2024
Indian Express· 4 days agoLet's begin...The contribution of quick commerce sales to the overall e-commerce sales of fast-moving consumer goods companies has doubled in a year, executives from top firms, including Dabur ...